Does a positive Clostridioides difficile antigen (glutamate dehydrogenase assay) indicate an active infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

No, a positive GDH (glutamate dehydrogenase) antigen test alone does NOT indicate active C. difficile infection.

A positive GDH test only confirms the presence of C. difficile organism (both toxigenic and non-toxigenic strains) but cannot distinguish between active infection, colonization, or non-toxigenic strains—you must perform confirmatory toxin testing or molecular testing to diagnose actual CDI.

Why GDH Alone is Insufficient

The 2018 IDSA/SHEA guidelines explicitly state that GDH immunoassays detect a common antigen present in ALL C. difficile isolates, including non-toxigenic strains that do not cause disease 1. The test has:

  • High sensitivity (91.1%) but low specificity (91.2%) 2
  • Cannot differentiate between colonization and true infection
  • Must be combined with another test in a multistep algorithm 1

The Correct Diagnostic Approach

The guidelines strongly recommend using GDH as a screening test only, followed by confirmatory testing 1:

Two-Step Algorithm (Recommended):

  1. Screen with GDH (high sensitivity catches most cases)
  2. If GDH positive → Perform toxin A/B immunoassay OR nucleic acid amplification test (NAAT)
  3. If GDH negative → CDI effectively ruled out (100% negative predictive value) 3, 4

Three-Step Algorithm (Alternative):

  1. GDH screening
  2. Toxin testing
  3. If discordant (GDH+/toxin-) → Arbitrate with NAAT

Clinical Significance of GDH+/Toxin- Results

This is a critical pitfall: 63% of GDH-positive/toxin-negative patients actually harbor toxigenic C. difficile 5. These patients:

  • Have significantly worse outcomes, including higher in-hospital mortality 6
  • Should NOT be dismissed as simple colonizers
  • Require clinical correlation and often confirmatory NAAT testing 5

Key Clinical Caveats

  • Never test asymptomatic patients - colonization rates are high, especially in hospitalized patients 1
  • Never test infants ≤12 months - colonization is nearly universal without clinical significance 1
  • Only test unformed stools from symptomatic patients with ≥3 unformed stools in 24 hours 1
  • Do not repeat testing within 7 days of the same diarrheal episode 1
  • Never perform test of cure - patients can remain colonized for months after successful treatment 1

Bottom Line for Clinical Practice

When you receive a positive GDH result, treat it as a screening positive that requires confirmation. The patient may have active CDI, may be colonized with toxigenic strains, or may harbor non-toxigenic C. difficile. Clinical correlation with symptoms plus confirmatory toxin or molecular testing is mandatory before initiating treatment 1, 7, 8.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.